FNY Investment Advisers LLC Makes New Investment in Axon Enterprise, Inc $AXON

Key Points

• FNY Investment Advisers LLC has made a new investment in Axon Enterprise, Inc by purchasing 650 shares valued at approximately $538,000 during the second quarter.
• Analysts are optimistic about Axon, with recent price target increases leading to a consensus rating of "Moderate Buy" and a target price of $841.64.
• Axon reported strong earnings with an EPS of $2.12 for the most recent quarter, surpassing estimates and achieving 32.6% year-over-year revenue growth.

FNY Investment Advisers LLC purchased a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 650 shares of the biotechnology company's stock, valued at approximately $538,000.

Other institutional investors have also modified their holdings of the company. Hemington Wealth Management grew its stake in shares of Axon Enterprise by 70.8% in the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company's stock worth $33,000 after acquiring an additional 17 shares in the last quarter. TCTC Holdings LLC grew its stake in shares of Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC grew its stake in shares of Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after acquiring an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC acquired a new position in shares of Axon Enterprise in the first quarter worth $32,000. Finally, Banque Transatlantique SA acquired a new position in shares of Axon Enterprise in the first quarter worth $31,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $707.04 on Wednesday. The company has a 50-day simple moving average of $735.50 and a 200-day simple moving average of $720.82. Axon Enterprise, Inc has a one year low of $422.38 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The stock has a market capitalization of $55.51 billion, a price-to-earnings ratio of 174.58, a PEG ratio of 26.53 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million during the quarter, compared to analysts' expectations of $641.77 million. During the same period in the prior year, the company earned $1.20 earnings per share. The business's revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Activity

In related news, President Joshua Isner sold 15,919 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the transaction, the president directly owned 238,379 shares of the company's stock, valued at $177,892,712.54. This represents a 6.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Hadi Partovi bought 1,358 shares of the stock in a transaction on Wednesday, August 13th. The shares were bought at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the transaction, the director directly owned 237,938 shares of the company's stock, valued at $176,074,120. This trade represents a 0.57% increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 59,932 shares of company stock valued at $45,115,616 over the last ninety days. 5.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. JPMorgan Chase & Co. boosted their target price on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a research note on Thursday, July 17th. Wolfe Research assumed coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They set an "outperform" rating for the company. Craig Hallum upgraded shares of Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 target price for the company in a research note on Tuesday, August 5th. Bank of America boosted their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Finally, JMP Securities reiterated a "market outperform" rating and set a $825.00 target price on shares of Axon Enterprise in a research note on Monday, September 29th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $841.64.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.